Inclisiran inhibits hepatic synthesis of proprotein convertase subtilisin–kexin type 9. Previous studies suggest that inclisiran might provide sustained reductions in low-density lipoprotein (LDL) ...
Please provide your email address to receive an email when new articles are posted on . For patients who could not achieve their LDL goal on statins alone, an inclisiran-first strategy lowered LDL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results